Home › Funds › RBO & CO LLC › ABT

RBO & CO LLC position in ABT

ABBOTT LABORATORIES · Health Care

RBO & CO LLC reported holding 212,453 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$21.0M, representing 3.57% of its reported portfolio and ranking #7 among its reported holdings. RBO & CO LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)212.45K sh
Reported value held$21.00M
Portfolio Weight3.57%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How RBO & CO LLC's ABT position evolved

RBO & CO LLC first disclosed a stake in ABT in Q3 2023 at 223,397 shares (US$21.6M). The position peaked in Q2 2025 at 215,803 shares, worth US$29.4M. Across 13 filings, RBO & CO LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 212,453 shares valued at US$21.0M — a reduction of -2,120 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 223.40K $21.64M New
Q4 2023 220.89K $24.31M Reduce
Q1 2024 211.81K $24.07M Reduce
Q2 2024 210.97K $21.92M Hold
Q3 2024 212.61K $24.24M Add
Q4 2024 215.90K $24.42M Add
Q1 2025 215.83K $28.63M Hold
Q2 2025 215.80K $29.35M Hold
Q3 2025 217.81K $29.17M Add
Q4 2025 218.40K $27.36M Hold
Q1 2026 217.81K $22.36M Hold
Q2 2026 214.57K $19.47M Reduce
Q3 2026 212.45K $21.00M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has RBO & CO LLC held ABT?

RBO & CO LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is RBO & CO LLC's current position in ABT?

As of Q3 2026, RBO & CO LLC holds 212.45K shares of ABT (ABBOTT LABORATORIES), valued at $21.00M, representing 3.57% of its reported portfolio and ranking #7.

Has RBO & CO LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), RBO & CO LLC reduced its position in ABT. The position peaked in Q2 2025 at 215.80K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.